AChE/BuChE-IN-8
AChE/BuChE-IN-8 is a dual AChE and BuChE inhibitor, with an AChE IC50 of 1.18 μM, a human AChE Ki of 1.2 μM, and a BuChE IC50 of 2.34 μM. AChE/BuChE-IN-8 acts as an antiproliferative agent and antioxidant, exerts antiproliferative effects on colon cancer cells, scavenges free radicals, and exhibits reducing power. AChE/BuChE-IN-8 can be used in the research of Alzheimer's disease and colorectal adenocarcinoma.
For research use only. We do not sell to patients.
- Formula: C24H18F2N6O2
- Molecular Weight:460.44
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
AChE 1.18 μM (IC50) |
AChE 1.2 μM (Ki) |
BuChE 2.34 μM (IC50) |
In Vitro
AChE/BuChE-IN-8 (Compound 6d) is a mixed-type hAChE inhibitor that binds to both free enzyme and enzyme-substrate complex simultaneously. It exhibits an AChE IC50 of 1.18 μM and a BuChE IC50 of 2.34 μM, with synergistic competitive (Ki = 1.2 μM) and non-competitive (Ki' = 2.5 μM) inhibitory effects[1].
AChE/BuChE-IN-8 (48 h) exhibits moderate antiproliferative activity against Caco-2 colon cancer cells (IC50 = 4.37 μM), with a selectivity index of 7.43[1].
AChE/BuChE-IN-8 exhibits potent free radical scavenging activity (IC50 = 12.1 μM).
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 460.44
-
Formula C24H18F2N6O2
-
SMILES
FC1=CC=C(N2C=C(COC3=CC=C(OCC4=CN(C5=CC=C(F)C=C5)N=N4)C=C3)N=N2)C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)